Imagine facing a debilitating illness, only to discover it could also be silently attacking your brain. That's the unsettling reality emerging from new research on dengue fever. A groundbreaking analysis reveals a significant link between acute dengue infection and an increased risk of neurological complications, particularly for older adults. This isn't just about the fever and aches; it's about the potential long-term impact on your cognitive and motor functions.
Why is this so important right now? Singapore, grappling with a rising tide of dengue cases, underscores the urgent need to understand the full spectrum of dengue's effects. Globally, dengue incidence is on the rise, making this research crucial for clinicians and public health officials worldwide. We need to move beyond treating the immediate symptoms and focus on long-term surveillance and early intervention strategies.
The study, a comprehensive population-based cohort analysis, examined data from 65,207 adults in Singapore diagnosed with acute dengue infection between 2017 and 2023. Researchers compared these individuals to a control group of 1,616,865 uninfected individuals, utilizing national registry data to paint a clear picture of the potential neurological consequences.
The results were striking. Within 30 days of infection, the dengue group exhibited significantly higher odds of experiencing a new neurological event. The adjusted odds ratios (aORs) speak volumes: any new neurological event (aOR 9.69; 95% CI 6.59 to 14.90), memory loss (aOR 3.19; 95% CI 1.36 to 8.69), movement disorders (aOR 7.10; 95% CI 2.49 to 29.18), and other neurological events (aOR 14.32; 95% CI 8.61 to 26.04) were all substantially elevated in the dengue-infected group. And this is the part most people miss: these elevated risks persisted for up to 90 days after the initial infection.
But here's where it gets controversial... While the odds were significantly higher, the actual increased burden remained modest, with less than one additional neurological event per 100 cases. Does this mean the risk is overblown? Or does it highlight the need to identify those individuals most vulnerable to these complications?
Interestingly, the increased risks for memory loss (aOR 2.99; 95% CI 1.30 to 7.87) and movement disorders (aOR 6.38; 95% CI 2.23 to 25.96) were primarily concentrated in adults aged 60 and over, particularly during periods when serotype 3 dengue was dominant. This suggests that older adults and specific dengue strains may pose a greater neurological threat.
What does this mean for you and your loved ones? The findings underscore the critical importance of proactive neurological assessment following a dengue infection, especially for older adults. Clinicians may need to revise their follow-up protocols to include targeted neurological screening during the first 90 days post-illness. This could involve simple cognitive tests or more comprehensive neurological examinations, depending on individual risk factors.
The future of dengue research should focus on unraveling the mechanisms behind neurological injury caused by the virus. Identifying early markers that can help stratify risk is also crucial. This would allow for more personalized and responsive clinical care pathways, ultimately leading to safer outcomes for dengue patients.
This study raises several important questions. Should neurological screening become a routine part of dengue follow-up care, especially for older adults? What specific markers could help identify individuals at higher risk of neurological complications? And how can public health authorities better prepare for and mitigate the potential long-term neurological impact of dengue fever? Share your thoughts and experiences in the comments below.
Reference:
Wee LE et al. Neurological events associated with acute dengue infection. JAMA Neurol. 2025;DOI:10.1001/jamaneurol.2025.4608.
This article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/).
